| Product NDC: | 10544-025 |
| Proprietary Name: | Cephalexin |
| Non Proprietary Name: | Cephalexin |
| Active Ingredient(s): | 500 mg/1 & nbsp; Cephalexin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10544-025 |
| Labeler Name: | Blenheim Pharmacal, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065152 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101105 |
| Package NDC: | 10544-025-14 |
| Package Description: | 14 CAPSULE in 1 BOTTLE (10544-025-14) |
| NDC Code | 10544-025-14 |
| Proprietary Name | Cephalexin |
| Package Description | 14 CAPSULE in 1 BOTTLE (10544-025-14) |
| Product NDC | 10544-025 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cephalexin |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20101105 |
| Marketing Category Name | ANDA |
| Labeler Name | Blenheim Pharmacal, Inc. |
| Substance Name | CEPHALEXIN |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |